Close Menu

NEW YORK – GenMark Diagnostics reported after the close of the market on Tuesday a 118 percent increase in second quarter revenues, driven by COVID-19 testing sales.

The Carlsbad, California-based molecular diagnostics firm reported $40.1 million in revenue, up from $18.4 million in Q2 of 2019 and beating the consensus analyst estimate of $32.7 million.

The firm booked ePlex revenues of $35.2 million for the quarter, representing 195 percent growth over the prior-year quarter, with average annuity per analyzer up 74 percent to $188,000.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.